MedRhythms Announces an Expansion of Intellectual Property Portfolio, Securing Patent on Audio Engine for Digital Therapeutics Platform

PORTLAND, MaineApril 17, 2020 /PRNewswire/ — MedRhythms, a Portland, Maine-based company building direct stimulation digital therapeutics that use sensors, software, and music to measure and improve walking, announced today the issuance of patent US20190022351A1 by the United States Patent and Trademark Office (USPTO).

This is the second granted patent in MedRhythms’ portfolio. The patent, entitled “Enhancing Music for Repetitive Motion Activities,” covers the audio engine enabling MedRhythms’ digital therapeutics platform. Read more

Related Posts

Bangor will be abuzz with Maine science at annual festival

The Maine Science Festival’s headlining event will be a major collaboration with a local arts organization for the second year in...

23 March 2023

Report: National Institutes of Health added $264M to Maine economy in 2022

The National Institutes of Health supported 1,950 jobs and $264 million in economic activity in Maine during 2022 through $112.7 million in grants and...

22 March 2023

Northern Light completes deal to outsource diagnostics to Quest

Quest Diagnostics (NYSE: DGX), a Secaucus, N.J.-based diagnostic information services provider with a national footprint, said Monday that it has completed the acquisition...

21 March 2023